Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

PDUFA Becomes US FDA's Billion Dollar Baby

Aug 01 2018

• By Derrick Gingery

FDA entrance sign 2016

Related Content

FDA May Not Implement User Fee Workload Adjuster In PDUFA VI

Apr 02 2018

ANDA Submissions To US FDA Expected To Decline; Generic User Fees For FY 2019 Will Rise

Jul 29 2018

Biosimilar User Fee Forecast: Unchanged Or Lower In FY 2019, US FDA Says

Jul 31 2018

US FDA Hiring For Senior Staff Vacancies Boosted By Cures Act, Pilot Program – Gottlieb

May 08 2018

Will PDUFA VI Fee Structure Changes Slow Revenue Growth?

Jul 25 2016

Office Of New Drugs Reorg Is Bigger Than Expected: US FDA Adds 11 Review Divisions

Jun 04 2018

Additional Topics

United States FDA Review Pathway Regulation BioPharmaceutical

More from US FDA

More from Agency Leadership

Twitter feed RSS feed RSS feed

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.